As more patients around the world are managing chronic diseases, there's a growing need for knowledge. From understanding the benefits of joining a trial to assessing the value of a therapy, education is a key to fostering positive health behaviors and better outcomes. IQVIA can help you maintain an ongoing dialog with patients, to build more informed engagement across the product lifecycle
Actively involve patients in their own healthcare to improve treatment experience and outcomes.Talking the Patients’ Language, IQVIA White Paper
As more complex specialty drugs are introduced, the need for education and training increases. For some patients — for example those with rare diseases — education is crucial as even providers may not have much information. It is therefore crucial that both patients and providers are engaged and educated regarding both disease and treatment.
Edgar Dale’s model for learning retention focuses on multimodal programs and on simulation, or learning by doing.
Not all patients are the same. Each one of them has different needs and a preferred learning style. Using a variety of formats — print, video, digital, mobile, and face-to-face with providers — can help meet patients where they are and engage them in their treatments.
Self-management can only go so far. Patients need support from providers, payers and opinion leaders, but also from their families and friends. IQVIA can help you develop appropriate educational materials for all these different support groups at each stage of the lifecycle and treatment journey — from trials to launch in market.
The pipeline of oncology drugs in clinical development has expanded by more than 60 percent over the last five years. IQVIA surveyed 98 EU oncologists to understand what they need to help their patients get the most out of cancer care.
Design programs that meet patient needs, improve adherence, make the patient journey easier, and support better outcomes.
Develop a full, multi-tactic communications strategy to reach and engage patients and other stakeholders.